Patents Assigned to INFLAMMATORY RESPONSE RESEARCH, INC.
  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 9937166
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: April 10, 2018
    Assignee: Inflammatory Response Research, Inc.
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 9925183
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: March 27, 2018
    Assignee: Inflammatory Response Research, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 9669026
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 6, 2017
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of vasculitis
    Patent number: 9669025
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: June 6, 2017
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 9522148
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: December 20, 2016
    Assignee: INFLAMMATORY RESPONSE RESEARCH, INC.
    Inventor: Bruce Chandler May